EverlyWell

Kwo most recently worked at Anthem, but has also held positions at Harvard Medical School, telehealth giant Amwell and medical device company Medtronic.

The new acquisition is set to help Everly Health grow its women's health offerings. 

This week's top stories include the AstraZeneca vaccine showing 79% efficacy but facing questions about using outdated information, Everlywell forming a new at-home lab testing subsidiary, and the VA reviewing its EHR modernization program.

PWNHealth will rebrand as Everly Health Solutions and will operate as an independent arm of Everly Health.

Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.

Also: The Consumer Technology Association releases industry standards focused on health AI trust; new updates in the home COVID-19 testing market.

The company projects that sales of its testing kits will triple by the end of 2020.

The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.

Nurx, Carbon Health and Everlywell have officially halted their mail-order testing-kit services. But at least one startup is still moving to secure an Emergency Use Authorization for its at-home rapid serology diagnostic.

[Since this article was published, the FDA has released an alert warning that it has not yet authorized any COVID-19 home testing kits]